AIGH Capital Management Discloses 9.9% Stake in Vaccinex, Inc.

TL;DR

**AIGH Capital Management owns 9.9% of Vaccinex, Inc. as of Dec 31, 2023.**

AI Summary

AIGH Capital Management, LLC, a Maryland-based investment firm, filed an amended SC 13G/A on February 7, 2024, disclosing its ownership in Vaccinex, Inc. As of December 31, 2023, AIGH beneficially owned 1,247,061 shares of Vaccinex's common stock, representing 9.9% of the company's outstanding shares. This filing indicates a significant, though not controlling, stake by an institutional investor, which could signal confidence in Vaccinex's future or simply be part of a diversified portfolio strategy.

Why It Matters

This filing shows a notable institutional investor, AIGH Capital Management, holds a significant portion of Vaccinex, Inc. stock, which can influence investor perception and potentially provide a floor for the stock price due to their large holding.

Risk Assessment

Risk Level: low — This filing indicates a significant institutional holding, which generally adds stability rather than risk to a stock.

Analyst Insight

Investors should note the significant institutional ownership by AIGH Capital Management, LLC, as it could imply a level of confidence in Vaccinex, Inc. However, this filing alone doesn't provide a reason to buy or sell; further research into Vaccinex's fundamentals and AIGH's investment strategy is warranted.

Key Numbers

• 1,247,061 — Shares Beneficially Owned (The total number of Vaccinex, Inc. shares owned by AIGH Capital Management, LLC as of December 31, 2023.)
• 9.9% — Percent of Class (The percentage of Vaccinex, Inc.'s common stock owned by AIGH Capital Management, LLC.)
• 817,061 — Sole Voting Power Shares (The number of shares over which AIGH Capital Management, LLC has sole voting power.)
• December 31, 2023 — Date of Event (The date as of which the ownership stake was calculated for this filing.)
• February 7, 2024 — Filing Date (The date this amended SC 13G/A was filed with the SEC.)

Key Players & Entities

• AIGH Capital Management, LLC (company) — the reporting person and investment firm
• Vaccinex, Inc. (company) — the subject company whose shares are being reported
• Orin Hirschman (person) — the individual associated with the filing entity
• Maryland (company) — place of organization for AIGH Capital Management, LLC
• Rochester, NY (company) — business address for Vaccinex, Inc.

Forward-Looking Statements

• AIGH Capital Management, LLC will maintain a significant stake in Vaccinex, Inc. (AIGH Capital Management, LLC) — medium confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

• formsc13ga.htm (SC 13G/A) — 107KB
• 0001493152-24-005339.txt ( ) — 108KB

(a) above and Item 4 of each cover page

Item 2(a) above and Item 4 of each cover page. (d) Title of Class of Securities: Common Stock, $0.0001 par value per share (e) CUSIP Number: 918640202 ITEM 3: IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________. ITEM 4: OWNERSHIP. See Item s 5,6,7,8 and 9 of each cover page. ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE

View Full Filing

View this SC 13G/A filing on SEC EDGAR